News
Drug Development
FDA
Drug Delivery
Deals
Business
Policy
Cell and Gene Therapy
Weight Loss
Rare Disease
Cancer
Job Trends
Artificial Intelligence
NextGen: Top Start Ups to Watch
Podcasts
Reports
Webinars
Press Releases
All News & Releases
Insights
Jobs
Career Advice
Companies
Hotbeds
More
Best Places to Work
Employer Resources
Post Jobs
Talent Solutions
Advertise
Submit a Press Release
SUBSCRIBE
Menu
SUBSCRIBE
Show Search
News
Drug Development
FDA
Drug Delivery
Deals
Business
Policy
Cell and Gene Therapy
Weight Loss
Rare Disease
Cancer
Job Trends
Artificial Intelligence
NextGen: Top Start Ups to Watch
Podcasts
Reports
Webinars
Press Releases
All News & Releases
Insights
Jobs
Career Advice
Companies
Hotbeds
More
Best Places to Work
Employer Resources
Post Jobs
Talent Solutions
Advertise
Submit a Press Release
Search Query
Submit Search
Search Results
Submit
Looking for jobs?
Search jobs
Close
685,029 Results
Type
Article (39023)
Company Profile (279)
Press Release (645727)
Section
Business (203856)
Career Advice (1988)
Deals (35361)
Drug Delivery (85)
Drug Development (80787)
Employer Resources (168)
FDA (16086)
Job Trends (14803)
News (344518)
Policy (32433)
Tag
Academia (2530)
Alliances (49060)
Alzheimer's disease (1225)
Approvals (16015)
Artificial intelligence (126)
Bankruptcy (352)
Best Places to Work (11529)
Biotechnology (200)
Breast cancer (116)
Cancer (1037)
Cardiovascular disease (91)
Career advice (1658)
Cell therapy (224)
Clinical research (64137)
Collaboration (366)
Compensation (191)
COVID-19 (2529)
C-suite (87)
Data (1064)
Diabetes (150)
Diagnostics (6131)
Earnings (84798)
Employer resources (146)
Events (109350)
Executive appointments (280)
FDA (16594)
Funding (330)
Gene therapy (172)
GLP-1 (572)
Government (4322)
Healthcare (18663)
Infectious disease (2611)
Inflammatory bowel disease (104)
Interviews (308)
IPO (16284)
Job creations (3623)
Job search strategy (1416)
Layoffs (412)
Legal (7851)
Lung cancer (165)
Manufacturing (170)
Medical device (13170)
Medtech (13175)
Mergers & acquisitions (19135)
Metabolic disorders (392)
Neuroscience (1482)
NextGen Class of 2024 (6500)
Non-profit (4463)
Northern California (1422)
Obesity (227)
Opinion (178)
Patents (98)
People (56205)
Phase I (19911)
Phase II (28247)
Phase III (21068)
Pipeline (445)
Postmarket research (2553)
Preclinical (8473)
Radiopharmaceuticals (234)
Rare diseases (206)
Real estate (5889)
Regulatory (21498)
Research institute (2308)
Resumes & cover letters (349)
Southern California (1264)
Startups (3560)
United States (13044)
Vaccines (547)
Weight loss (166)
Date
Today (47)
Last 7 days (923)
Last 30 days (3454)
Last 365 days (35435)
2024 (32134)
2023 (40074)
2022 (51173)
2021 (55712)
2020 (54088)
2019 (46541)
2018 (35020)
2017 (32109)
2016 (31480)
2015 (37552)
2014 (31318)
2013 (26345)
2012 (28570)
2011 (29263)
2010 (27328)
Location
Africa (713)
Arizona (190)
Asia (37088)
Australia (6051)
California (3194)
Canada (1256)
China (240)
Colorado (142)
Connecticut (143)
Europe (79425)
Florida (439)
Georgia (112)
Illinois (336)
Indiana (191)
Kansas (96)
Maryland (569)
Massachusetts (2531)
Michigan (153)
Minnesota (268)
New Jersey (923)
New York (927)
North Carolina (689)
Northern California (1422)
Ohio (134)
Pennsylvania (818)
South America (1091)
Southern California (1264)
Texas (436)
Utah (88)
Washington State (353)
685,029 Results for "neurorx inc".
Filters
Sort By
Relevance
Relevance
Newest
Oldest
Press Releases
ABS Bio, Inc. announces strategic investment by 3 Boomerang Capital
◆Investment to support services growth. ◆Industry veterans join board of directors, including John Chickosky as Executive Chairman, and Greg Swanberg and Martin LeBlanc as Directors.
November 14, 2024
·
1 min read
Drug Development
Our Mission at Voyager Therapeutics: Define the Future of Neurogenetic Medicines
We are in an unprecedented time in neurotherapeutics. Medicines that address the causative disease biology underlying central nervous system
May 8, 2024
·
2 min read
·
Voyager Therapeutics, Inc.
Business
Relief Therapeutics Holding SA and NRx Pharmaceuticals, Inc. Announce Close of Definitive Settlement Agreements-December 20, 2022
RELIEF THERAPEUTICS Holding SA and NRx Pharmaceuticals, Inc. a clinical-stage central nervous system biopharmaceutical company, today announced the close of the definitive settlement agreements to resolve the pending litigation between Relief and NRx Pharmaceuticals’ wholly owned subsidiary, NeuroRx, Inc.
December 20, 2022
·
4 min read
Pharm Country
NeuroRx Announces Zyesami™ (Aviptadil) Has Been Selected for Inclusion in NIH-Sponsored Global Clinical Trial to Include Aviptadil and Remdesivir
NeuroRx, Inc. reports that Aviptadil, to be supplied by NeuroRx, has been identified by the National Institutes of Health as one of two drugs selected for inclusion in a phase III multicenter clinical trial that will include the United States and multiple foreign countries.
April 6, 2021
·
5 min read
Business
NeuroRX and TFF Pharmaceuticals Announce Entering Into Feasibility Collaboration
NeuroRx, Inc. and TFF Pharmaceuticals, Inc. (NASDAQ: TFFP) are announcing that the companies have entered into a feasibility and material transfer agreement (Feasibility Agreement).
March 9, 2021
·
11 min read
Press Releases
Boston Scientific Closes Acquisition of Axonics, Inc.
November 15, 2024
·
5 min read
Press Releases
Progyny, Inc. to Present at Jefferies London Healthcare Conference
November 14, 2024
·
1 min read
Press Releases
Meiji Seika Pharma Announces Investment in ARCALIS, Inc.
November 14, 2024
·
3 min read
Press Releases
Exagen Inc. to Participate in Fourth Quarter Investor Conferences
November 14, 2024
·
1 min read
Press Releases
Verrica Pharmaceuticals Announces Litigation Settlement with Dormer Laboratories, Inc.
Verrica Pharmaceuticals Inc. today announced the settlement of litigation with Dormer Laboratories, Inc. (“Dormer Labs”).
July 1, 2024
·
5 min read
1 of 68,503
Next
